ArticleNMC case report journal2022

A Case of Relapsed Primary Central Nervous System Lymphoma Treated with CD19-directed Chimeric Antigen Receptor T Cell Therapy.

Ryo Mizuta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.